课题基金 / 基金详情

Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.

Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.
脂质纳米颗粒介导的 CRISPR/Cas9 基因编辑治疗神经系统疾病。
批准号:
462295
负责人:
Leavitt Blair R
金额:
$55.45万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2027-03-01

项目摘要

项目成果

Leavitt Blair R的其他基金

相似基金

相关文献

中文摘要
翻译
脑部疾病是加拿大人口死亡和残疾的主要原因 这是一个巨大的经济和社会负担。大多数脑部疾病无法治愈,生活质量逐渐下降,并随着年龄的增长而变得更加常见。
英文摘要
Brain disease is a leading cause of death and disability in the Canadian population representing an immense economic and societal burden. Most brain diseases have no cure, progressively decrease quality of life, and become more common with increasing age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.
  • 批准号:
    456004
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Leavitt Blair R
  • 依托单位:
CHAnging Rare disorders of LysInE metabolism
  • 批准号:
    431267
  • 项目类别:
    Operating Grants
  • 资助金额:
    $32.78万
  • 财政年份:
    2020
  • 负责人:
    Leavitt Blair R
  • 依托单位:
Characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epileptic encephalopathy caused by antiquitin mutations.
  • 批准号:
    419183
  • 项目类别:
    Operating Grants
  • 资助金额:
    $44.58万
  • 财政年份:
    2020
  • 负责人:
    Leavitt Blair R
  • 依托单位:
Development, characterization and treatment of a novel conditional mouse model of pyridoxine-dependent epileptic encephalopathy caused by antiquitin mutations.
  • 批准号:
    387291
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2018
  • 负责人:
    Leavitt Blair R
  • 依托单位:
海外基金